-
Pfizer Settles Most Bextra And Celebrex Drug Injury Cases
Company Will Pay $745 Million In Settlements To Conclude 90% Of These Lawsuits (Posted by Tom Lamb at DrugInjuryWatch.com) An October 17, 2008 Wall Street Journal (WSJ) article, "Pfizer to Settle Celebrex and Bextra…
-
A New “Double-Dose” Pill Drug Recall Is Issued By ETHEX Corp.
First It Was Their Morphine Tablets; Now ETHEX Dextroamphetamine 5mg Pills May Be Oversized And Contain Two Times The Active Ingredient (Posted by Tom Lamb at DrugInjuryWatch.com) By means of an October 16, 2008…
-
Pfizer Is Accused Of Withholding Or Altering Drug Study Results About Neurontin That Were Not Favorable
If Drug Companies Put Sales Above Efficacy And Safety, Should They Get Legal Immunity By Means Of Federal Preemption Doctrine? (Posted by Tom Lamb at DrugInjuryWatch.com) In the first part of October 2008 we…
-
Congress Will Investigate Digitek Recall And What FDA Knew About Actavis Manufacturing Problems
After Earlier Class 1 Recall Of Digitek, All Acvtavis Drugs Manufactured At Its Little Falls, NJ Plant Were Recalled In August 2008 (Posted by Tom Lamb at DrugInjuryWatch.com) On October 8, 2008 Representatives John…
-
October 2008 List Of 50 Blogs Covering Various Aspects Of The Pharmaceutical Realm
Interested In Reading About Pharmacy, Pharmacists, Pharmacology, Or Big Pharma? Then This List Is For You (Posted by Tom Lamb at DrugInjuryWatch.com) Over at the Nursing Degree Guide web site, Joel West has an…
-
New Warning About Dostinex Side Effect Fibrotic Cardiac Valvulopathy In U.K.
September 2008 Dear Doctor Letter From Pfizer Follows 2007 EMEA Safety Review Of Cabergoline (Posted by Tom Lamb at DrugInjuryWatch.com) Pfizer's Dostinex (cabergoline) remains on the market despite the January 2007 reports in the…